Editorial: Approval of abortion pills, delayed for five years, must not be postponed any longer
Translated from Korean and summarized by DistantNews. Read the original for the full story.
At a glance
- A South Korean civil society coalition urged the Ministry of Food and Drug Safety to approve abortion medication by Sept. 28.
- The call follows President Lee Jae-myungโs July directive to introduce the medication and an interpretation that it can be imported without amending the law.
- The coalition said women need a formal healthcare system for safe access, while lawmakers and the government must address related legal and insurance issues.
A five-year wait for abortion medication approval must end, a South Korean civil society coalition said as it set Sept. 28 as the deadline for action.
The Network for Securing Everyoneโs Right to Safe Abortion held a news conference on Sept. 2 outside the Ministry of Food and Drug Safety. It urged the ministry to approve the medication by Sept. 28, which is International Safe and Legal Abortion Day. If approval does not come by then, the group said 100 petitioners would visit the ministry the following day.
The coalitionโs demand comes as ministries discuss the issue after President Lee Jae-myung ordered the introduction of abortion medication in July. On Aug. 19, the Ministry of Government Legislation interpreted existing law as allowing the medication to be imported without a legal amendment. The Ministry of Health and Welfare, Ministry of Justice, Ministry of Food and Drug Safety, Ministry of Government Legislation and Ministry of Gender Equality and Family are now holding consultations under the Office for Government Policy Coordination.
The editorial criticizes both the National Assembly, which it says has delayed alternative legislation in the name of โsocial consensus,โ and the government, which has failed to build a healthcare system while insisting legislation must come first. It says the ministry has kept blocking approval for medication designated an essential medicine by the World Health Organization in 2005, leaving women to buy expensive drugs through unofficial channels without confirmed safety and effectiveness.
It calls for rapid review based on scientific evidence gathered overseas and for a healthcare system that provides abortion consultations and prescriptions without discrimination based on socioeconomic status. Questions over permitted gestational limits, prescription rules, health insurance coverage and prices remain. The editorial urges officials to reduce unnecessary procedures and costs, while calling on the National Assembly to revise the Criminal Act and Mother and Child Health Act.
The governmentโs continued neglect is irresponsible.
Originally published by Hankyoreh in Korean. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.